|
Number of patients (male/female) (n)
|
116 (65/51)
|
|
Age (years)
|
62 ± 13
|
|
Body mass index (kg/m2)
|
21.3 ± 3.3
|
|
Type 2 diabetes mellitus (+/−)(n)
|
48/68
|
|
Treatment (%)
|
|
ARB/ACE inhibitor
|
31.0
|
|
Iron therapy
|
37.1
|
|
Systolic blood pressure (mmHg)
|
149 ± 24
|
|
Diastolic blood pressure (mmHg)
|
88 ± 16
|
|
Heart rate (/min)
|
77 ± 12
|
|
Duration of hemodialysis (years)
|
7.6 ± .2
|
|
Kt/V (range)
|
1.10 ± 0.31
|
|
Hemoglobin A1c (%)
|
5.4 ± 0.7
|
|
Glycated albumin (%)
|
16.7 ± 3.8
|
|
Triglyceride (mg/dL)
|
139 ± 110
|
|
Total cholesterol (mg/dL)
|
169 ± 32
|
|
Low-density lipoprotein cholesterol (mg/dL)
|
94 ± 26
|
|
High-density lipoprotein cholesterol (mg/dL)
|
51 ± 19
|
|
Albumin (g/dL)
|
3.8 ± 0.3
|
|
Creatinine (mg/dL)
|
11.26 ± 3.08
|
|
Uric acid (mg/dL)
|
6.9 ± 1.4
|
|
Urea nitrogen (mg/dL)
|
62.9 ± 13.5
|
|
Corrected calcium (mg/dL)
|
9.0 ± 0.8
|
|
Phosphate (mg/dL)
|
5.7 ± 1.3
|
|
C-reactive protein (mg/dL)
|
0.27 ± 0.79
|
|
β2-microglobumin (mg/L)
|
24.9 ± 5.4
|
|
Total carnitine (μmol/L)
|
44.5 ± 11.7
|
|
Free carnitine (μmol/L)
|
28.6 ± 8.1
|
|
Acyl carnitine (μmol/L)
|
15.9 ± 4.7
|
|
Acyl carnitine/free carnitine
|
0.6 ± 0.1
|
|
Skin autofluorescence (arbitrary unit)
|
3.4 ± 0.7
|
|
Left ventricular ejection fraction (%)
|
66.9 ± 8.9
|
